NDC 0121-0898
Atovaquone
Atovaquone
Atovaquone is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Pai Holdings, Llc. The primary component is Atovaquone.
| Product ID | 0121-0898_0d67fa4c-b36a-4d81-8e7d-a661db92df22 |
| NDC | 0121-0898 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Atovaquone |
| Generic Name | Atovaquone |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-10-11 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210692 |
| Labeler Name | PAI Holdings, LLC |
| Substance Name | ATOVAQUONE |
| Active Ingredient Strength | 750 mg/5mL |
| Pharm Classes | Antimalarial [EPC], Antiprotozoal [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |